These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 17303774)

  • 41. C-reactive protein levels and coronary artery disease incidence and mortality in apparently healthy men and women: the EPIC-Norfolk prospective population study 1993-2003.
    Boekholdt SM; Hack CE; Sandhu MS; Luben R; Bingham SA; Wareham NJ; Peters RJ; Jukema JW; Day NE; Kastelein JJ; Khaw KT
    Atherosclerosis; 2006 Aug; 187(2):415-22. PubMed ID: 16257408
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Serum level of secretory phospholipase A2 (sPLA2) as a predictor of restenosis after coronary angioplasty].
    Korotaeva AA; Provatorov SI; Samoĭlova EV; Kaminnyĭ AI; Sumarokov AB; Pirkova AA; Samko AN; Prokazova NV
    Ter Arkh; 2002; 74(4):12-5. PubMed ID: 12043230
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduction of circulating secretory phospholipase A2 levels by anti-tumor necrosis factor chimeric monoclonal antibody in patients with severe Crohn's disease. Relation between tumor necrosis factor and secretory phospholipase A2 in healthy humans and in active Crohn's disease.
    van Dullemen HM; Wolbink GJ; Wever PC; van der Poll T; Hack CE; Tytgat GN; van Deventer SJ
    Scand J Gastroenterol; 1998 Oct; 33(10):1094-8. PubMed ID: 9829366
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Secretory phospholipase A2-IIa is involved in prostate cancer progression and may potentially serve as a biomarker for prostate cancer.
    Dong Z; Liu Y; Scott KF; Levin L; Gaitonde K; Bracken RB; Burke B; Zhai QJ; Wang J; Oleksowicz L; Lu S
    Carcinogenesis; 2010 Nov; 31(11):1948-55. PubMed ID: 20837598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Point of care testing of phospholipase A2 group IIA for serological diagnosis of rheumatoid arthritis.
    Liu NJ; Chapman R; Lin Y; Mmesi J; Bentham A; Tyreman M; Abraham S; Stevens MM
    Nanoscale; 2016 Feb; 8(8):4482-5. PubMed ID: 26854217
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of distinct phospholipases A2 and their modulators in meconium aspiration syndrome in human neonates.
    De Luca D; Minucci A; Tripodi D; Piastra M; Pietrini D; Zuppi C; Conti G; Carnielli VP; Capoluongo E
    Intensive Care Med; 2011 Jul; 37(7):1158-65. PubMed ID: 21567110
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Type II secretory phospholipase A2 binds to ischemic flip-flopped cardiomyocytes and subsequently induces cell death.
    Nijmeijer R; Willemsen M; Meijer CJ; Visser CA; Verheijen RH; Gottlieb RA; Hack CE; Niessen HW
    Am J Physiol Heart Circ Physiol; 2003 Nov; 285(5):H2218-24. PubMed ID: 12805018
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Type IIA secretory phospholipase A2 up-regulates cyclooxygenase-2 and amplifies cytokine-mediated prostaglandin production in human rheumatoid synoviocytes.
    Bidgood MJ; Jamal OS; Cunningham AM; Brooks PM; Scott KF
    J Immunol; 2000 Sep; 165(5):2790-7. PubMed ID: 10946311
    [TBL] [Abstract][Full Text] [Related]  

  • 49. High-sensitivity C-reactive protein, lipoprotein-associated phospholipase A2, and outcome after ischemic stroke.
    Elkind MS; Tai W; Coates K; Paik MC; Sacco RL
    Arch Intern Med; 2006 Oct; 166(19):2073-80. PubMed ID: 17060536
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus.
    Lagorce-Pagès C; Paraf F; Wendum D; Martin A; Fléjou JF
    Virchows Arch; 2004 May; 444(5):426-35. PubMed ID: 15045585
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human group IIA secretory phospholipase A2 potentiates Ca2+ influx through L-type voltage-sensitive Ca2+ channels in cultured rat cortical neurons.
    Yagami T; Ueda K; Asakura K; Nakazato H; Hata S; Kuroda T; Sakaeda T; Sakaguchi G; Itoh N; Hashimoto Y; Hori Y
    J Neurochem; 2003 May; 85(3):749-58. PubMed ID: 12694401
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of secretory type IIA phospholipase A2 (sPLA2-IIA) as a glycyrrhizin (GL)-binding protein and the GL-induced inhibition of the CK-II-mediated stimulation of sPLA2-IIA activity in vitro.
    Shimoyama Y; Sakamoto R; Akaboshi T; Tanaka M; Ohtsuki K
    Biol Pharm Bull; 2001 Sep; 24(9):1004-8. PubMed ID: 11558558
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Autocrine and paracrine transcriptional regulation of type IIA secretory phospholipase A2 gene in vascular smooth muscle cells.
    Jaulmes A; Janvier B; Andreani M; Raymondjean M
    Arterioscler Thromb Vasc Biol; 2005 Jun; 25(6):1161-7. PubMed ID: 15802623
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of secretory phospholipase A₂ in women with metabolic syndrome.
    Pop D; Sitar-Taut A; Bodisz G; Zdrenghea D; Cebanu M; Stanca L
    Indian J Med Res; 2013 Dec; 138(6):866-72. PubMed ID: 24521628
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Secretory phospholipase A2 receptor-mediated activation of cytosolic phospholipase A2 in murine bone marrow-derived mast cells.
    Fonteh AN; Atsumi G; LaPorte T; Chilton FH
    J Immunol; 2000 Sep; 165(5):2773-82. PubMed ID: 10946309
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacology of LY315920/S-5920, [[3-(aminooxoacetyl)-2-ethyl-1- (phenylmethyl)-1H-indol-4-yl]oxy] acetate, a potent and selective secretory phospholipase A2 inhibitor: A new class of anti-inflammatory drugs, SPI.
    Snyder DW; Bach NJ; Dillard RD; Draheim SE; Carlson DG; Fox N; Roehm NW; Armstrong CT; Chang CH; Hartley LW; Johnson LM; Roman CR; Smith AC; Song M; Fleisch JH
    J Pharmacol Exp Ther; 1999 Mar; 288(3):1117-24. PubMed ID: 10027849
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inflammatory mediators in dengue virus infection in children: interleukin-6 and its relation to C-reactive protein and secretory phospholipase A2.
    Juffrie M; Meer GM; Hack CE; Haasnoot K; Sutaryo ; Veerman AJ; Thijs LG
    Am J Trop Med Hyg; 2001 Jul; 65(1):70-5. PubMed ID: 11504411
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Adiponectin and risk of coronary heart disease in apparently healthy men and women (from the EPIC-Norfolk Prospective Population Study).
    Côté M; Cartier A; Reuwer AQ; Arsenault BJ; Lemieux I; Després JP; Wareham NJ; Kastelein JJ; Boekholdt SM; Khaw KT
    Am J Cardiol; 2011 Aug; 108(3):367-73. PubMed ID: 21550577
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor.
    Morioka Y; Saiga A; Yokota Y; Suzuki N; Ikeda M; Ono T; Nakano K; Fujii N; Ishizaki J; Arita H; Hanasaki K
    Arch Biochem Biophys; 2000 Sep; 381(1):31-42. PubMed ID: 11019817
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues.
    Masuda S; Murakami M; Ishikawa Y; Ishii T; Kudo I
    Biochim Biophys Acta; 2005 Oct; 1736(3):200-10. PubMed ID: 16188494
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.